Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 759,598 | 626,757 | 720,962 | 639,559 | 581,889 |
| Marketable Securities | 448,146 | 197,835 | 248,710 | 513,115 | 681,835 |
| Receivables | 605,329 | 616,697 | 548,893 | 560,777 | 551,208 |
| Inventories | 289,066 | 269,313 | 267,878 | 280,038 | 293,950 |
| Other current assets | 438,281 | 420,529 | 468,788 | 415,523 | 371,713 |
| TOTAL | $2,540,420 | $2,131,131 | $2,255,231 | $2,409,012 | $2,480,595 |
| Non-Current Assets | |||||
| PPE Net | 1,641,634 | 1,641,791 | 1,571,521 | 1,604,573 | 1,637,083 |
| Investments And Advances | 991,299 | 767,262 | 767,848 | 1,242,984 | 1,424,477 |
| Intangibles | 2,919,140 | 2,853,963 | 2,907,550 | 2,960,754 | 3,009,699 |
| TOTAL | $5,552,073 | $5,263,016 | $5,246,919 | $5,808,311 | $6,071,259 |
| Total Assets | $8,092,493 | $7,394,147 | $7,502,150 | $8,217,323 | $8,551,854 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 162,529 | 143,699 | 144,476 | 121,356 | 118,534 |
| Accrued Expenses | 665,923 | 553,796 | 487,803 | 432,887 | 500,755 |
| TOTAL | $1,050,122 | $824,480 | $755,658 | $682,330 | $714,942 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,066,379 | 1,068,776 | 1,069,725 | 1,076,201 | 1,080,207 |
| aiOther Non-Current Liabilities | 294,125 | 398,011 | 256,774 | 256,749 | 253,846 |
| TOTAL | $1,592,928 | $1,499,466 | $1,535,202 | $1,584,399 | $1,575,030 |
| Total Liabilities | $2,643,050 | $2,323,946 | $2,290,860 | $2,266,729 | $2,289,972 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 240,912 | 238,302 | 241,915 | 266,998 | 269,601 |
| Common Shares | 124 | 124 | 129 | 139 | 144 |
| Retained earnings | 1,872,481 | 1,646,852 | 1,405,340 | 1,131,523 | 1,068,890 |
| Other shareholders' equity | 31,735 | 30,535 | 12,082 | 64,467 | 90,928 |
| TOTAL | $5,449,443 | $5,070,201 | $5,211,290 | $5,950,594 | $6,261,882 |
| Total Liabilities And Equity | $8,092,493 | $7,394,147 | $7,502,150 | $8,217,323 | $8,551,854 |